Nelson Lab - UCLA
  • Upload

  • Log in

  • Sign up

Search on MyScienceWork
1 News 179 Publications 5 Members

Inhibition of X-Linked Inhibitor of Apoptosis with Embelin Differentially Affects Male versus Female Behavioral Outcome ... PDF available through Get Fulltext Research

Hill, C.A. Alexander, M.L. McCullough, L.D. Fitch, R.H.

Published in Developmental Neuroscience

Hypoxia-ischemia (HI; concurrent oxygen/blood deficiency) and associated encephalopathy represent a common cause of neurological injury in premature/low-birth-weight infants and term infants with birth complications. Resulting behavioral impairments include cognitive and/or sensory processing deficits, as well as language disabilities, and clinical...

Clinical Genome Sequencing PDF available through Get Fulltext Research

Green, Robert C. Rehm, Heidi L. Kohane, Isaac S.

Published in Genomic and Personalized Medicine

High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regula... PDF available through Get Fulltext Research

Cabrera, Paula V Pang, Mabel Marshall, Jamie L Kung, Raymond Nelson, Stanley F Stalnaker, Stephanie H Wells, Lance Crosbie-Watson, Rachelle H Baum, Linda G

Published in The Journal of biological chemistry

Duchenne muscular dystrophy is an X-linked disorder characterized by loss of dystrophin, a cytoskeletal protein that connects the actin cytoskeleton in skeletal muscle cells to extracellular matrix. Dystrophin binds to the cytoplasmic domain of the transmembrane glycoprotein β-dystroglycan (β-DG), which associates with cell surface α-dystroglycan (...

Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix mol...

Pope, W B Mirsadraei, L Lai, A Eskin, A Qiao, J Kim, H J Ellingson, B Nghiemphu, P L Kharbanda, S Soriano, R H ...

Published in AJNR. American journal of neuroradiology

ADC histogram analysis can stratify outcomes in patients with GBM treated with bevacizumab. Therefore, we compared gene expression between high-versus-low ADC tumors to identify gene expression modules that could underlie this difference and impact patient prognosis. Up-front bevacizumab-treated patients (N = 38) with newly diagnosed glioblastoma w...

ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.

Willer, Tobias Lee, Hane Lommel, Mark Yoshida-Moriguchi, Takako de Bernabe, Daniel Beltran Valero Venzke, David Cirak, Sebahattin Schachter, Harry Vajsar, Jiri Voit, Thomas ...

Published in Nature genetics

Walker-Warburg syndrome (WWS) is clinically defined as congenital muscular dystrophy that is accompanied by a variety of brain and eye malformations. It represents the most severe clinical phenotype in a spectrum of diseases associated with abnormal post-translational processing of a-dystroglycan that share a defect in laminin-binding glycan synthe...

A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. PDF available through Get Fulltext Research

Casey, Jillian P Magalhaes, Tiago Conroy, Judith M Regan, Regina Shah, Naisha Anney, Richard Shields, Denis C Abrahams, Brett S Almeida, Joana Bacchelli, Elena ...

Published in Human genetics

Autism spectrum disorder (ASD) is a highly heritable disorder of complex and heterogeneous aetiology. It is primarily characterized by altered cognitive ability including impaired language and communication skills and fundamental deficits in social reciprocity. Despite some notable successes in neuropsychiatric genetics, overall, the high heritabil...

Genome-wide association study of intelligence: additive effects of novel brain expressed genes.

Sk, Loo C, Shtir Ae, Doyle E, Mick Jj, Mcgough J, Mccracken J, Biederman Sl, Smalley Rm, Cantor Sv, Faraone ...

Published in Journal of the American Academy of Child & Adolescent Psychiatry

Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance. PDF available through Get Fulltext Research

Shi, Hubing Moriceau, Gatien Kong, Xiangju Lee, Mi-Kyung Lee, Hane Koya, Richard C Ng, Charles Chodon, Thinle Scolyer, Richard A Dahlman, Kimberly B ...

Published in Nature communications

The development of acquired drug resistance hampers the long-term success of B-RAF inhibitor therapy for melanoma patients. Here we show (V600E)B-RAF copy-number gain as a mechanism of acquired B-RAF inhibitor resistance in 4 out of 20 (20%) patients treated with B-RAF inhibitor. In cell lines, (V600E)B-RAF overexpression and knockdown conferred B-...

Exome Sequencing Identifies PDE4D Mutations in Acrodysostosis PDF available through Get Fulltext Research

Lee, Hane Graham, John M. Jr. Rimoin, David L. Lachman, Ralph S. Krejci, Pavel Tompson, Stuart W. Nelson, Stanley F. Krakow, Deborah Cohn, Daniel H.

Published in The American Journal of Human Genetics

Acrodysostosis is a dominantly-inherited, multisystem disorder characterized by skeletal, endocrine, and neurological abnormalities. To identify the molecular basis of acrodysostosis, we performed exome sequencing on five genetically independent cases. Three different missense mutations in PDE4D, which encodes cyclic AMP (cAMP)-specific phosphodies...

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway... PDF available through Get Fulltext Research

Konkankit, Veerauo V Kim, Won Koya, Richard C Eskin, Ascia Dam, Mai-Anh Nelson, Stanley Ribas, Antoni Liau, Linda M Prins, Robert M

Published in Journal of Translational Medicine

BackgroundThe lack of effective treatments for gliomas makes them a significant health problem and highlights the need for the development of novel and innovative treatment approaches. Immunotherapy is an appealing strategy because of the potential ability for immune cells to traffic to and destroy infiltrating tumor cells. However, the absence of ...

  • ← Previous
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • …
  • 16
  • Next →
Powered by Polaris
  • About the Lab
  • Our Research
  • FAQ